# Rakovina Therapeutics

Type: Company (RKV)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/rakovina-therapeutics
Canonical HTML page: https://gethealthbrief.com/entity/rakovina-therapeutics

## Recent coverage (1 stories)

### Rakovina Therapeutics Upsizes Financing to $2M to Fuel Oncology Pipeline
2026-02-21 03:06:05 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Rakovina Therapeutics has announced an upsized financing package totaling $2.0 million through a combination of convertible debentures and a private placement. The capital infusion is earmarked for near-term operations as the company advances its DNA damage response (DDR) cancer therapies.
Full story: https://gethealthbrief.com/story/rakovina-therapeutics-upsized-financing-oncology

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.